Abstract:Research purpose: The low treatment effectiveness in major depressive disorder (MDD) may be caused by the subjectiveness in clinical examination and the lack of quantitative tests. Objective biomarkers derived from magnetic resonance imaging (MRI) may support clinical experts during decision-making. Numerous studies have attempted to identify such MRI-based biomarkers. However, the majority is uni-modal (based on a single MRI modality) and focus on either MDD diagnosis or outcome. Uncertainty remains regarding whether key features or classification models for diagnosis may also be used for outcome prediction. Therefore, we aim to find multi-modal predictors of both, MDD diagnosis and outcome. By addressing these research questions using the same dataset, we eliminate between-study confounding factors. Various structural (T1-weighted, T2-weighted, diffusion tensor imaging (DTI)) and functional (resting-state and task-based functional MRI) scans were acquired from 32 MDD and 31 healthy control (HC) subjects during the first visit at the investigational site (baseline). Depression severity was assessed at baseline and 6 months later. Features were extracted from the baseline MRI images with different modalities. Binary 6-months negative and positive outcome (NO; PO) classes were defined based on relative (to baseline) change in depression severity. Support vector machine models were employed to separate MDD from HC (diagnosis) and NO from PO subjects (outcome). Classification was performed through a uni-modal (features from a single MRI modality) and multi-modal (combination of features from different modalities) approach. Principal results: Our results show that DTI features yielded the highest uni-modal performance for diagnosis and outcome prediction: mean diffusivity (AUC (area under the curve) = 0.701) and the sum of streamline weights (AUC = 0.860), respectively. Multi-modal ensemble classifiers with T1-weighted, resting-state functional MRI and DTI features improved classification performance for both diagnosis and outcome (AUC = 0.746 and 0.932, respectively). Feature analyses revealed that the most important features were located in frontal, limbic and parietal areas. However, the modality or location of these features was different between diagnostic and prognostic models. Major conclusions: Our findings suggest that combining features from different MRI modalities predict MDD diagnosis and outcome with higher performance. Furthermore, we demonstrated that the most important features for MDD diagnosis were different and located in other brain regions than those for outcome. This longitudinal study contributes to the identification of objective biomarkers of MDD and its outcome. Follow-up studies may further evaluate the generalizability of our models in larger or multi-center cohorts.

Machine Learning Models Identify Multimodal Measurements Highly Predictive of Transdiagnostic Symptom Severity for Mood, Anhedonia, and Anxiety

Multi-modal MRI for objective diagnosis and outcome prediction in depression

Connectome-based models can predict early symptom improvement in major depressive disorder

Machine Learning of Functional Connectivity to Biotype Alcohol and Nicotine Use Disorders

Prediction of Anxious Depression Using Multimodal Neuroimaging and Machine Learning

Predicting Individualized Clinical Measures by a Generalized Prediction Framework and Multimodal Fusion of MRI Data.

Multimodal integration of neuroimaging and genetic data for the diagnosis of mood disorders based on computer vision models

A Systematic Evaluation of Machine Learning–Based Biomarkers for Major Depressive Disorder

Combination of Spontaneous Regional Brain Activity and HTR1A/1B DNA Methylation to Predict Early Responses to Antidepressant Treatments in MDD

Individualized functional connectome identified generalizable biomarkers for psychiatric symptoms in transdiagnostic patients

Optimizing Antidepressant Efficacy: Generalizable Multimodal Neuroimaging Biomarkers for Prediction of Treatment Response

Multimodal Predictors of Treatment Response in Major Depressive Disorder: Advancing Personalized Medicine in Psychiatry

Multimodal Mental Health Digital Biomarker Analysis from Remote Interviews using Facial, Vocal, Linguistic, and Cardiovascular Patterns

Diagnosis of Major Depressive Disorder Using Machine Learning Based on Multisequence MRI Neuroimaging Features

Identification of Diagnostic Markers for Major Depressive Disorder Using Machine Learning Methods

Individualized Prediction of Anxiety and Depressive Symptoms Using Gray Matter Volume in a Non-Clinical Population.

Examining factors related to low performance of predicting remission in participants with major depressive disorder using neuroimaging data and other clinical features

Deep Multimodal Predictome for Studying Mental Disorders

Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach

Identification of multimodal brain imaging biomarkers in first-episode drugs-naive major depressive disorder through a multi-site large-scale MRI consortium data